A Product and Pipeline Analysis of the U.S. Multiple Sclerosis Therapeutics Market
A Product and Pipeline Analysis of the U.S. Multiple Sclerosis Therapeutics Market
RELEASE DATE
13-Feb-2012
13-Feb-2012
REGION
North America
North America
Research Code: 9837-00-35-00-00
SKU: HC00756-NA-MR_04388
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00756-NA-MR_04388
Description
The U.S. multiple sclerosis market is entering a new phase of growth driven by the development of innovative therapeutic platforms. Oral therapies are likely to revolutionize the treatment paradigm of multiple sclerosis by improving dosing and patient compliance.
This research service presents a marketed and pipeline analysis of the U.S. multiple sclerosis market. The purpose of this study is to highlight the current market landscape, provide a competitive analysis of all marketed and pipeline drugs as well as a pipeline analysis of all drugs in development for multiple sclerosis.
Table of Contents
Executive Summary
Introduction
Competitive Landscape
RRMS Overview
SPMS Overview
PPMS Overview
PRMS Overview
Product Profiles
Certification
Legal Disclaimer
About Frost & Sullivan
Popular Topics
The U.S. multiple sclerosis market is entering a new phase of growth driven by the development of innovative therapeutic platforms. Oral therapies are likely to revolutionize the treatment paradigm of multiple sclerosis by improving dosing and patient compliance. This research service presents a marketed and pipeline analysis of the U.S. multiple sclerosis market. The purpose of this study is to highlight the current market landscape, provide a competitive analysis of all marketed and pipeline drugs as well as a pipeline analysis of all drugs in development for multiple sclerosis.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9837-00-35-00-00 |
Is Prebook | No |